192 related articles for article (PubMed ID: 23434473)
1. In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor.
Podolin PL; Bolognese BJ; Foley JF; Long E; Peck B; Umbrecht S; Zhang X; Zhu P; Schwartz B; Xie W; Quinn C; Qi H; Sweitzer S; Chen S; Galop M; Ding Y; Belyanskaya SL; Israel DI; Morgan BA; Behm DJ; Marino JP; Kurali E; Barnette MS; Mayer RJ; Booth-Genthe CL; Callahan JF
Prostaglandins Other Lipid Mediat; 2013; 104-105():25-31. PubMed ID: 23434473
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
Yang L; Cheriyan J; Gutterman DD; Mayer RJ; Ament Z; Griffin JL; Lazaar AL; Newby DE; Tal-Singer R; Wilkinson IB
Chest; 2017 Mar; 151(3):555-563. PubMed ID: 27884766
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment.
Davis BB; Liu JY; Tancredi DJ; Wang L; Simon SI; Hammock BD; Pinkerton KE
Biochem Biophys Res Commun; 2011 Jul; 410(3):494-500. PubMed ID: 21683067
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
Revermann M
Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.
Smith KR; Pinkerton KE; Watanabe T; Pedersen TL; Ma SJ; Hammock BD
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2186-91. PubMed ID: 15684051
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice.
Morgan LA; Olzinski AR; Upson JJ; Zhao S; Wang T; Eisennagel SH; Hoang B; Tunstead JR; Marino JP; Willette RN; Jucker BM; Behm DJ
J Cardiovasc Pharmacol; 2013 Apr; 61(4):291-301. PubMed ID: 23232840
[TBL] [Abstract][Full Text] [Related]
7. Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in vivo.
Zhu P; Peck B; Licea-Perez H; Callahan JF; Booth-Genthe C
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2487-93. PubMed ID: 21798825
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.
Lazaar AL; Yang L; Boardley RL; Goyal NS; Robertson J; Baldwin SJ; Newby DE; Wilkinson IB; Tal-Singer R; Mayer RJ; Cheriyan J
Br J Clin Pharmacol; 2016 May; 81(5):971-9. PubMed ID: 26620151
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
Ghosh S; Chiang PC; Wahlstrom JL; Fujiwara H; Selbo JG; Roberds SL
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):453-8. PubMed ID: 18312493
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
[TBL] [Abstract][Full Text] [Related]
14. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
15. Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome.
Zheng J; Plopper CG; Lakritz J; Storms DH; Hammock BD
Am J Respir Cell Mol Biol; 2001 Oct; 25(4):434-8. PubMed ID: 11694448
[TBL] [Abstract][Full Text] [Related]
16. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
17. Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition.
Wang SB; Pang XB; Zhao Y; Wang YH; Zhang L; Yang XY; Fang LH; Du GH
J Asian Nat Prod Res; 2012; 14(11):1084-92. PubMed ID: 23106500
[TBL] [Abstract][Full Text] [Related]
18. Cigarette Smoke-Induced Pulmonary Inflammation and Autophagy Are Attenuated in Ephx2-Deficient Mice.
Li Y; Yu G; Yuan S; Tan C; Lian P; Fu L; Hou Q; Xu B; Wang H
Inflammation; 2017 Apr; 40(2):497-510. PubMed ID: 28028752
[TBL] [Abstract][Full Text] [Related]
19. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
